Flutemetamol Terminated Phase 3 Trials for Alzheimer's Disease (AD) / Dementia / Mild Cognitive Impairment (MCI) Diagnostic

Indications	Status	Purpose	Phase
DBCOND0049114 (Alzheimer's Disease (AD)) DBCOND0017457 (Dementia) DBCOND0038137 (Mild Cognitive Impairment (MCI))	Terminated	Diagnostic	3

clinicaltrials.gov Identifier	Title	Drugs
NCT02353949	Investigating the Clinical Consequences of Flutemetamol-PET-scanning	Flutemetamol (DB15058) Flutemetamol (18F) (DB09151)